Research Article
WITHDRAWN: Excess Mortality in Alzheimer’s Patients on Anti-Aβ Monoclonal Antibodies
https://doi.org/10.21203/rs.3.rs-5282702/v2
This work is licensed under a CC BY 4.0 License
posted
You are reading this latest preprint version
13 November, 2024 Editorial Update. Based on additional information received, Research Square has changed the withdrawal status of this preprint from an author-initiated withdrawal to an editorial withdrawal. This action was taken due to a breach of our preprint terms of service, which require consent from all listed authors prior to submission.
Editorial notes are used to provide important context regarding the topic of a preprint or to alert readers to potential issues concerning that preprint or a downstream publication associated with it. For more information on editorial notes, see our Editorial Policies.
13 November, 2024 Editorial Update. Based on additional information received, Research Square has changed the withdrawal status of this preprint from an author-initiated withdrawal to an editorial withdrawal. This action was taken due to a breach of our preprint terms of service, which require consent from all listed authors prior to submission.
13 November, 2024 Editorial Update. Based on additional information received, Research Square has changed the withdrawal status of this preprint from an author-initiated withdrawal to an editorial withdrawal. This action was taken due to a breach of our preprint terms of service, which require consent from all listed authors prior to submission.
posted
You are reading this latest preprint version